DrugDashboards

Montelukast Sodium

Montelukast · MONTELUKAST SODIUM 5 mg/1 · Tablet, Chewable · Oral · Ajanta Pharma USA Inc.

NDC 27241-0017-03 · 30 TABLET, CHEWABLE in 1 BOTTLE · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. The price is down 9% over the past year, to $0.0818 per unit.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.1678per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0857per TABweighted avg manufacturer price $0.0397 · May 1, 2022

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2$0.3Dec 2015Aug 2022$0.0818
81 price points · per · last surveyed Aug 1, 2022 · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$27.00
Reported to Texas DSHS · 2022 annual filing · Ajanta Pharma Limited

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2023)

$185
30 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for montelukast (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA203328
TE code
—
Approval date
Jul 31, 2015
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Montelukast (Tablet, Chewable)

LabelerStrengthFirst seenLast seen
Proficient Rx LPMONTELUKAST SODIUM 5 mg/1Jul 15, 2026Sep 3, 2026
Ajanta Pharma USA Inc.MONTELUKAST SODIUM 5 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCMONTELUKAST SODIUM 4 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCMONTELUKAST SODIUM 5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Montelukast Sodium — NDC 27241-0017-03," retrieved September 3, 2026, https://drugdashboards.com/drug/27241001703.

Free to cite with attribution — see how the data is put together.